维普中文期刊产品整合服务
29篇 您的检索式:作者名="ARGO CK"
    题名 作者 年代 出处 被引量
1Therapy of NAFLD:insulin sensitizing agents显示文摘CALDWELL SH ARGO CK AL-OSAIMI AM 2006J Clin Gastroenterol2006,40,31:1
2Systematic review of risk factors for fibrosisprogression in non-alcoholic steatohepatitis显示文摘Argo CK Northup PG Al-Osaimi AM 2009J Hepatol2009,51,:1
3Therapy of NAFLD : insulin sensitizing agents 显示文摘Caldwell SH Argo CK Al-Osaimi AM 2006J Clin Gastroenterol2006,40,3:1
4Inflammation in nonalcoholic steatohepatitis 显示文摘Harmon RC Tiniakos DG Argo CK 2011Expert Rev Gastroenterol Hepatol2011,5,2:1
5Epidemiology and natural history of non-alcoholic steatohepatitis显示文摘Argo CK Caldwell SH 2009Clin Liver Dis2009,13,:1
6Divergent effects of peroxisome proliferator- activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis显示文摘Caldwell SH Argo CK 2007Hepatology2007,46,2:1
7Epidemiology and natural history of non-alcoholic steatohepatitis 显示文摘Argo CK Caldwell SH 2009Clin Liver Dis2009,13,4:1
8Divergent effects of penoxisome proliferator -activated receptor - r ligands in human and mouee nonalcoholic steatohepatitis 显示文摘Caldwell SH Argo CK 2007Hepatology2007,46,2:1
9Epidemiology and natural history of non -alco- holic steatohepatitis显示文摘Argo CK Caidwell SH 2009Clin Liver Dis2009,13,4:1
10Statins in liver disease: a molehill, an iceberg, or neither? 显示文摘Argo CK Loria P Caldwell SH 2008Hepatology2008,48,2:1
11Therapy of NAFLD:insulin sensitizing agents显示文摘Caldwell SH Argo CK Al-Osaimi AM 2006J Clin Gastroenterol2006,40,1:1
12Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepati- tis显示文摘Argo CK Northup PG A1-Osaimi A 2009Journal of Hepatology2009,51,2:1
13Statins in liver disease:a molehill,an iceberg,or neither显示文摘Argo CK Loria P Caldwell SH 0,,02:1
14Liver allografts from hepati- tis C positive donors can offer good outcomes in hepatitis C positive recipients:a US National Transplant Registry analysis 显示文摘Northup PG Argo CK Nguyen DT 2010Transpl Int2010,23,:1
15Therapy of NAFLD: in- sulin Sensitizing Agents 显示文摘Caldwell SH Argo CK AI- Osaimi AM 2006J Clin Gastroenterol2006,,:1
16Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis显示文摘Northup PG Argo CK Nguyen DT 2010Transpl Int2010,23,10:1
17Therapy of NAFLD:antioxidants and cytoprotective agents显示文摘Chang CY Argo CK Al-Osaimi AM 2006J Clin Gastroenterol2006,,:1
18Therapy of NAFLD: antioxidants and cytoprotective agents 显示文摘Chang CY Argo CK A1-Osaimi AM 2006J Clin Gastroenterol2006,,:1
19Epidemiology and natural history of non-alcoholic steatohepatitis显示文摘Argo CK Caldwell SH 2009Clin Liver Dis2009,13,4:1
20Therapy of NAFLD: antioxidants and cytoprotective agents 显示文摘Chang CY Argo CK A1-Osaimi AM 2006J Clin Gastroenterol2006,40,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费